US
Europe

 

US
Europe

 

historymanagementboard of directors investors

press releasespress coverageelectronic press kit

media

 

ABOUT LUX

Lux Biosciences is a clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases.
With a first-in-class product in NDA/MAA submission stage and several exciting earlier-stage projects, Lux is building a revenue-generating, high-growth, and sustainable ophthalmic company.

 

   
  © 2009 Lux Biosciences, Inc. All rights reserved. Web Terms Deutsch Enlarged Text
   
   

 

LUVENIQ™LX214LX212proprietary technologiespipeline

uveitisdry eye syndromeage-related macular degeneration

indicationstechnologies

aboutophthalmicproducts &partnersnews &careerscontact us